SEOUL (SOUTH KOREA) – North Korea is expected to get nearly two million doses of AstraZeneca-Oxford COVID-19 vaccine by the first half of 2021, as reported by Yonhap on Thursday. It was citing a report published by COVAX Facility on Wednesday.
The COVAX Facility will provide 1.992 million doses of AstraZeneca/Oxford vaccines produced by the Serum Institute of India to the North Korea by the first half, the news report said.